Omecamtiv Mecarbil - Is It More Effective in Low EFs

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Grant Support/Research Contract (Personal) - Abbott Vascular; Amgen; AstraZenca; Bayer AG; Boehringer Ingelheim; Bristol-Myers Squibb; Cytokinetics; Medtronic; Novartis; Windtree Therapeutics
• Consultant Fee/Honoraria/Speaker's Bureau (Personal) - Abbott Vascular; Amgen; AstraZenca; Bayer AG; Boehringer Ingelheim; Bristol-Myers Squibb; Cytokinetics; Medtronic; Merck/Schering Plough; Novartis; Verily; Windtree Therapeutics